ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $100,000 | -97.6% | 37,495 | -93.1% | 0.00% | -97.1% |
| Q2 2016 | $4,217,000 | -39.5% | 540,611 | -40.1% | 0.04% | -47.8% |
| Q1 2016 | $6,965,000 | -33.5% | 902,202 | -7.1% | 0.07% | -31.6% |
| Q4 2015 | $10,476,000 | +113.6% | 970,862 | +36.8% | 0.10% | +63.3% |
| Q3 2015 | $4,905,000 | +38.9% | 709,855 | +78.1% | 0.06% | +30.4% |
| Q2 2015 | $3,532,000 | +125.3% | 398,626 | +150.6% | 0.05% | +130.0% |
| Q1 2015 | $1,568,000 | +56.2% | 159,040 | +94.0% | 0.02% | +53.8% |
| Q4 2014 | $1,004,000 | +330.9% | 81,984 | +165.9% | 0.01% | +333.3% |
| Q2 2014 | $233,000 | – | 30,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |